In this study, we observed that berberine chloride (50 mg/kg) could significantly decrease the escape latency and increase the number of crossings over the platform position in the rats model of AD assayed by Morris water maze test, and could also increase both IL-1β and iNOS expression very significantly assayed by immunohistochemical method. This evidence concerns the gene IL1B and Alzheimer disease.